A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset

PloS One
Francis HaneOwen Bai

Abstract

In this work we use a hierarchical Bayesian paradigm to introduce a theoretical framework to determine an individual's Apolipoprotein ε4 (APOE4) genotype, which heavily influences both the age of onset and probability of acquiring Alzheimer's disease (AD). This calculation is based solely on an individual's family history. This APOE4 genotype estimation is then combined with a number of known factors that influence AD onset to produce a function that estimates the onset of AD as a function of age. We disseminated our Alzheimer's predictive tool online at http://www.alzheimerspredictor.com.

References

Nov 25, 1997·JAMA : the Journal of the American Medical Association
Jan 12, 1999·American Journal of Epidemiology·P N NemetzL T Kurland
Mar 10, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·L LetenneurJ F Dartigues
May 19, 2004·Archives of Neurology·Zoe ArvanitakisDavid A Bennett
Jul 17, 2009·The New England Journal of Medicine·Robert C GreenUNKNOWN REVEAL Study Group
Aug 13, 2009·JAMA : the Journal of the American Medical Association·Nikolaos ScarmeasYaakov Stern
Mar 19, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Jun 21, 2011·Nature Genetics·Günter U HöglingerGerard D Schellenberg
Nov 6, 2015·Alzheimer's Research & Therapy·Brandy L CallahanUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.